Insights+ Key Biosimilars Events of December 2019
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be
[Read More...]
Events
Insights+ Key Biosimilars Events of October 2019
Biosimilars are key alternatives for costly Biologics therapies and saving millions of dollars of patients in multiple diseases. Hence physicians are likely to
[Read More...]
Insights+ Key Biosimilars Events of September 2019
Biosimilars are key alternatives for costly Biologics therapies and saving millions of dollars of patients in multiple diseases. Hence physicians are likely to
[Read More...]
Insights+ Key Biosimilars Events of July 2019
Biosimilars are key alternatives for costly Biologics therapies and saving million dollars of patients in multiple diseases. Hence physicians are likely to adopt
[Read More...]
Insights+ Key Biosimilars Events of June 2019
Biosimilars are key alternatives for costly Biologics therapies and saving million dollars of patients in multiple diseases. Hence physicians are likely to adopt
[Read More...]
Insights+ Exclusive: An Analysis of Biopharma Companies Growth in Last 20 Years (1999-2018)
In the last 20 years the global Biopharma space has changed a lot with ups and downs of companies and their growth. This
[Read More...]